For the year ending 2025-12-31, NRXS had $1,268,202 increase in cash & cash equivalents over the period. -$6,463,993 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net sales | 3,569,282 |
| Cost of goods sold | 562,916 |
| Gross profit | 3,006,366 |
| Selling expenses | 2,279,974 |
| Research and development | 493,611 |
| Wages and benefits | 4,550,833 |
| Professional services | 1,296,368 |
| Legal settlement | 630,568 |
| Depreciation | 37,691 |
| Amortization | 21,810 |
| Other operating expenses | 1,525,419 |
| Operating loss | -7,829,908 |
| Financing charges | 30,240 |
| Interest expense | 73,969 |
| Change in fair value of warrant liability | 7,634 |
| Other income | 141,196 |
| Total other income (expense), net | 29,353 |
| Net loss | -7,800,555 |
| Amortization of debt discount and issuance cost | 0 |
| Issuance of common stock for non-cash consideration | 0 |
| Fair value of warrants issued for non-cash consideration | 0 |
| Provisions for losses on accounts receivable | 2,326 |
| Provision for losses on inventory | 30,070 |
| Loss on disposal of property and equipment | -7,878 |
| Non-cash lease expense | 23,092 |
| Financing charges | 30,240 |
| Change in fair value of warrant liability | 7,634 |
| Accounts receivable | -46,589 |
| Inventory | 242,874 |
| Prepaids and other current assets | -240,975 |
| Accounts payable | -457,583 |
| Accrued expenses | 1,082,727 |
| Customer deposits | -3,867 |
| Operating lease liability | -50,935 |
| Other non-current liabilities | -4,913 |
| Stock based compensation | 596,852 |
| Depreciation and amortization | 59,501 |
| Net cash used by operating activities | -6,432,843 |
| Proceeds from issuance of series b preferred stock | 0 |
| Proceeds from convertible notes | 0 |
| Financing fees paid | 0 |
| Proceeds from issuance of common stock, net of issuance costs | 7,728,423 |
| Deferred offering costs paid | 712,669 |
| Proceeds from exercised warrants | 1,098,192 |
| Principal payments on notes payable | 281,751 |
| Net cash provided by financing activities | 7,832,195 |
| Additions to property and equipment | 31,150 |
| Additions to intangible assets | 100,000 |
| Net cash used by investing activities | -131,150 |
| Net increase in cash and cash equivalents | 1,268,202 |
| Cash and cash equivalents at beginning of period | 3,696,870 |
| Cash and cash equivalents at end of period | 4,965,072 |
Neuraxis, INC (NRXS)
Neuraxis, INC (NRXS)